TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
XENE

Xenon Pharmaceuticals Inc

Healthcare · Biotechnology

36.90$ -2.9% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Xenon Pharmaceuticals Inc (XENE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,296 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet XENE
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
671 965 919 884 836 798 743 674 608 982 1,387 1,296
531 645 707 728 660 635 566 500 480 561 1,107 946
100 149 59 137 88 143 117 135 105 199 546 120
527 638 700 722 654 627 550 488 462 549 1,095 931
0.8 0.9 0.8 0.9 0.9 1.5 8.6 1.1 0.8 1.4 1.2 1.6
-0.8 0.0 – – – – – – – – – –
35 37 31 40 38 43 39 40 48 400 49 53
25 27 22 31 30 36 32 33 38 42 40 45
1.2 1.3 1.3 1.4 1.4 1.4 1.4 1.5 1.5 1.5 1.6 1.3
6.1 8.6 6.4 9.5 5.4 5.1 6.9 4.8 4.6 3.9 5.7 2.5
637 928 888 844 798 755 704 634 560 582 1,338 1,242
-620 -665 -713 -771 -834 -899 -965 -1,049 -1,140 -1,245 -1,348 -1,458
66 70 78 78 78 78 79 79 79 79 87 100

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?